These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 17445569

  • 1. Innate immunity-mediated allograft rejection and strategies to prevent it.
    Land WG.
    Transplant Proc; 2007 Apr; 39(3):667-72. PubMed ID: 17445569
    [Abstract] [Full Text] [Related]

  • 2. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
    Land WG, Gutmann T, Daar AS.
    Acta Chir Belg; 2008 Apr; 108(1):73-82. PubMed ID: 18411578
    [Abstract] [Full Text] [Related]

  • 3. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
    Goldstein DR, Palmer SM.
    J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
    [Abstract] [Full Text] [Related]

  • 4. Toll like receptors and acute allograft rejection.
    Goldstein DR.
    Transpl Immunol; 2006 Dec; 17(1):11-5. PubMed ID: 17157206
    [Abstract] [Full Text] [Related]

  • 5. Innate alloimmunity: history and current knowledge.
    Land W.
    Exp Clin Transplant; 2007 Jun; 5(1):575-84. PubMed ID: 17617046
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppressive strategies in organ transplantation in the light of innate immunity.
    Land WG.
    Exp Clin Transplant; 2006 Jun; 4(1):406-15. PubMed ID: 16827635
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of innate and adaptive immunity on rejection and tolerance.
    Kim IK, Bedi DS, Denecke C, Ge X, Tullius SG.
    Transplantation; 2008 Oct 15; 86(7):889-94. PubMed ID: 18852649
    [Abstract] [Full Text] [Related]

  • 9. Emerging role of innate immunity in organ transplantation part III: the quest for transplant tolerance via prevention of oxidative allograft injury and its consequences.
    Land WG.
    Transplant Rev (Orlando); 2012 Apr 15; 26(2):88-102. PubMed ID: 22000661
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.
    Palmer SM, Burch LH, Mir S, Smith SR, Kuo PC, Herczyk WF, Reinsmoen NL, Schwartz DA.
    Clin Transplant; 2006 May 15; 20(1):30-6. PubMed ID: 16556150
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activation of the innate immune system by the endogenous ligand hyaluronan.
    Shirali AC, Goldstein DR.
    Curr Opin Organ Transplant; 2008 Feb 15; 13(1):20-5. PubMed ID: 18660702
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of innate immunity in acute allograft rejection after lung transplantation.
    Palmer SM, Burch LH, Davis RD, Herczyk WF, Howell DN, Reinsmoen NL, Schwartz DA.
    Am J Respir Crit Care Med; 2003 Sep 15; 168(6):628-32. PubMed ID: 12773319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.